Chlorthenoxazine

CAS No. 132-89-8

Chlorthenoxazine( Chlorethylbenzmethoxazone )

Catalog No. M26647 CAS No. 132-89-8

Chlorthenoxazine has anti-inflammatory activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 78 Get Quote
5MG 113 Get Quote
10MG 159 Get Quote
25MG 287 Get Quote
50MG 447 Get Quote
100MG 651 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Chlorthenoxazine
  • Note
    Research use only, not for human use.
  • Brief Description
    Chlorthenoxazine has anti-inflammatory activity.
  • Description
    Chlorthenoxazine has anti-inflammatory activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Chlorethylbenzmethoxazone
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Anti-infection| Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    132-89-8
  • Formula Weight
    211.65
  • Molecular Formula
    C10H10ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClCCC1NC(=O)c2ccccc2O1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yoshimura H, et al. Comparative in vitro activity of 16 antimicrobial agents against Actinobacillus pleuropneumoniae. Vet Res Commun. 2002 Jan;26(1):11-9.
molnova catalog
related products
  • Mudanpioside C

    Mudanpioside C is a natural product from Paeonia lactiflora Pall.

  • 4-Methylcatechol

    4-methylcatechol is a metabolite of homoprotocatechuic acid. It is both a substrate and a suicide inhibitor of Catechol 23-dioxygenase. 4-methylcatechol is known to induce the production of brain-derived neurotrophic factor (BDNF). Recent studies have suggested that a lack of brain-derived neurotrophic factor (BDNF) in the limbic system may cause neuropathic pain.

  • IMR-1A

    IMR-1A is the metabolite of IMR-1 which is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L.